Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Mazzitelli

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Immunology|March 17, 2022
A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in MiceLorena M Coria, Lucas M Saposnik, Celeste Pueblas Castro, et al.
Ebiomedicine|August 21, 2022
Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort studyVanesa Seery, Silvina Raiden, Constanza Russo, et al.
Cell Reports. Medicine|July 26, 2021
Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single doseAndres H Rossi, Diego S Ojeda, Augusto Varese, et al.
Cell Reports. Medicine|August 4, 2022
Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273Carla A Pascuale, Augusto Varese, Diego S Ojeda, et al.
Nature|January 11, 2022
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftElisabetta Cameroni, John E Bowen, Laura E Rosen, et al.
Biorxiv : the Preprint Server for Biology|December 21, 2021
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftElisabetta Cameroni, Christian Saliba, John E Bowen, et al.
Mbio|January 25, 2022
Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over TimeMaría M Gonzalez Lopez Ledesma, Lautaro Sanchez, Diego S Ojeda, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Immunology|March 17, 2022
A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in MiceLorena M Coria, Lucas M Saposnik, Celeste Pueblas Castro, et al.
Ebiomedicine|August 21, 2022
Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort studyVanesa Seery, Silvina Raiden, Constanza Russo, et al.
Cell Reports. Medicine|July 26, 2021
Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single doseAndres H Rossi, Diego S Ojeda, Augusto Varese, et al.
Cell Reports. Medicine|August 4, 2022
Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273Carla A Pascuale, Augusto Varese, Diego S Ojeda, et al.
Nature|January 11, 2022
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftElisabetta Cameroni, John E Bowen, Laura E Rosen, et al.
Biorxiv : the Preprint Server for Biology|December 21, 2021
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftElisabetta Cameroni, Christian Saliba, John E Bowen, et al.
Mbio|January 25, 2022
Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over TimeMaría M Gonzalez Lopez Ledesma, Lautaro Sanchez, Diego S Ojeda, et al.
Pageof 2